This inventor holds 2 USPTO granted patents. Top assignees: Sankyo Company, Limited, Ube Industries, Inc.. Active years: 1977-1984.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tokyo, JA (1977)
- Hiromachi, JP (1984)
Company Filing History:


Years Active: 1977-1984
Title: The Innovations of Toshiharu Kamioka
Introduction
Toshiharu Kamioka is a notable inventor based in Hiromachi, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on pyrimidine derivatives and aminoalkanol derivatives. With a total of 2 patents, his inventions have the potential to impact the medical industry positively.
Latest Patents
Kamioka's latest patents include the development of new 4-anilinopyrimidine derivatives, which are characterized by a specific formula involving C1-C6 alkyl groups. These compounds are designed to enhance pharmaceutical compositions. Additionally, he has worked on aminoalkanol derivatives that serve as minor tranquilizers. These derivatives can be synthesized by reacting the corresponding 2-amino-α-phenylbenzylideneaminoalkanol derivative with an aminocarboxylic acid, showcasing his expertise in medicinal chemistry.
Career Highlights
Throughout his career, Kamioka has been associated with prominent companies such as Sankyo Company, Limited and Ube Industries, Inc. His work in these organizations has allowed him to refine his skills and contribute to various innovative projects in the pharmaceutical sector.
Collaborations
Kamioka has collaborated with notable coworkers, including Syunji Naruto and Yuji Akiyoshi. These partnerships have likely facilitated the exchange of ideas and fostered a collaborative environment for innovation.
Conclusion
Toshiharu Kamioka's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and drug development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile